At the news
? BEARISHIMPACT 6/10 PRESS-RELEASE filed Apr 23, 2026 at 16:05 ET
Outlook Therapeutics raised approximately $5.0 million through a registered direct offering of 16.1 million shares at $0.31 per share, accompanied by a concurrent private placement of unregistered warrants to purchase an additional 16.1 million shares at $0.31. The company also amended existing warrants to lower their exercise price from $2.26 to $0.31, aligning them with the new offering. Proceeds will be used for working capital and general corporate purposes.
- Raised $5.0 million gross proceeds via issuance of 16,129,033 shares at $0.31 per share.
- Concurrent private placement of unregistered warrants to purchase up to 16,129,033 shares at $0.31 per share, exercisable upon stockholder approval and charter amendment.
- Amended existing warrants for 2,142,854 shares, reducing exercise price from $2.26 to $0.31.
- Total potential proceeds from fully exercised warrants: additional $5.0 million (no assurance of exercise).
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access